Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity.
about
Predictors of subclinical cardiovascular disease in women with polycystic ovary syndrome: interrelationship of dyslipidemia and arterial blood pressure.The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controlsEndocrine autoimmune diseases and female infertility.The prevalence and metabolic characteristics of polycystic ovary syndrome in the Qatari population.The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome.Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance.Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease.Atrial natriuretic peptide, copeptin and adrenomedullin levels in polycystic ovary syndrome: a case-control study.The effect of obesity on inflammatory markers in patients with PCOS: a BMI-matched case-control study.Circulating SCUBE1 levels in women with polycystic ovary syndrome
P2860
Q35297432-4FFD8685-EE86-4159-A17D-85633DFD9353Q35312833-A23415DC-743E-43F7-AFE3-E3E844B9AF92Q38159892-1DB7D475-A023-423A-AE99-FA4EE67A0AA5Q40116439-A1EDFA2B-6E0B-4A75-A44C-DC4D244C0472Q40810438-292F00FF-7ABC-4970-A497-7C9D0325AF25Q40995589-5146CD57-7A88-4F81-8604-0C2F1E7D984AQ45169384-24079843-0272-4F55-B3E5-EE2D373244B6Q51281730-D0B3F658-0DEC-4E4A-B29A-568607A86804Q53061710-84C0BA61-7EEC-4509-9236-86CD0BB85D30Q58767791-B4972B5F-1C96-4549-BB76-FC64393C4D71
P2860
Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Polycystic ovary syndrome has ...... kers when matched for obesity.
@en
Polycystic ovary syndrome has ...... kers when matched for obesity.
@nl
type
label
Polycystic ovary syndrome has ...... kers when matched for obesity.
@en
Polycystic ovary syndrome has ...... kers when matched for obesity.
@nl
prefLabel
Polycystic ovary syndrome has ...... kers when matched for obesity.
@en
Polycystic ovary syndrome has ...... kers when matched for obesity.
@nl
P2093
P2860
P921
P356
P1476
Polycystic ovary syndrome has ...... kers when matched for obesity.
@en
P2093
A J Dawson
E S Kilpatrick
K M Naseem
P2860
P304
P356
10.1111/CEN.12137
P577
2013-05-11T00:00:00Z